Cohort profile: A Québec-based plasma donor biobank to study COVID-19 immunity (PlasCoV).
Marc GermainAntoine LewinRenée BazinMélanie DieudéJosée PerreaultAmélie BoivinYves GrégoireChristian RenaudPublished in: BMJ open (2023)
Donations from individuals who consented to participate before 1 October 2022 will be collected up until 31 March 2023. This plasma biobank will facilitate the conduct of longitudinal studies on COVID-19 immunity, thus helping to provide valuable insights into the anti-SARS-CoV-2 immune response and its persistence, and the effects of vaccination and variants on the specificity of the anti-SARS-CoV-2 immune response.